Translational Validation of 5HT7 Antagonists as a Treatment For Cognitive Impairment in Bipolar Disorder: A Proof of Principle Neuroimaging Study | C4C
Around 60% of people with Bipolar Disorder experience problems with attention and memory, known as cognitive impairment, which greatly affects the ability to work and hold relationships. This study measures brain and cognitive changes after participants use a drug that blocks a specific receptor in the brain, which could potentially improve cognitive impairment.